Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Sep 29;13(19):2471.
doi: 10.3390/healthcare13192471.

Aerobic Training-Induced Changes in Sedentary Time, Non-Exercise Physical Activity, and Sleep Among Breast Cancer Survivors and Postmenopausal Women Without Cancer

Affiliations

Aerobic Training-Induced Changes in Sedentary Time, Non-Exercise Physical Activity, and Sleep Among Breast Cancer Survivors and Postmenopausal Women Without Cancer

Francesco Sartor et al. Healthcare (Basel). .

Abstract

Background/Objectives: The 24 h activity cycle highlights the need to consider sedentary behavior (SED), non-exercise physical activity (NEPA), and sleep when introducing aerobic exercise. This study assessed changes in these components among breast cancer survivors (BCS) and non-oncologic menopausal women after a 3-month walking (W) or Nordic walking (NW) program. Methods: A total of 324 menopausal women participated: 156 non-oncologic (Meno), 102 BCS with natural menopause (BCS_Meno), and 66 BCS with medically induced menopause (BCS_Ind_Meno). Linear Mixed Effects (LME) modeling was applied. Age, BMI, hormonal therapy, cancer treatments, hypertension, sleep, and METs were included as covariates. Results: BCS_Meno and BCS_Ind_Meno had longer sleep durations at baseline (adj. diff.: +26.5 min/day, 95% CI 10.1 to 43.0; p = 0.002 and +25.7, 95% CI 6.7 to 44.6; p = 0.008). Sleep improved across all groups post-intervention (overall adj. effect = +17.4 min/day, 95% CI 4.8 to 30.0; p = 0.007). Higher sleep and METs were associated with reduced SED (sleep: β = -43.7 min/day per unit increase, -52.6 to -34.8; METs: β = -115.4, -126.4 to -104.4; both p < 0.001). A significant group × time interaction showed a decrease in SED in the BCS_Ind_Meno group (adj. diff. = -65.1 min/day, -102.8 to -27.4; p = 0.001). NEPA was negatively influenced by sleep (β = -8.7 min/day, -16.2 to -1.1, p = 0.024) and positively by METs (β = +121.1, 111.8 to 130.3; p < 0.001). NEPA increased only in BCS_Ind_Meno (adj. diff.: +70.6 min/day, 38.4 to 102.7; p < 0.001), not in BCS_Meno (+9.87, -18.7 to 38.4; p = 0.497). Conclusions: BCS_Ind_Meno showed the greatest benefits, with reduced SED, increased NEPA, and improved sleep. Sleep improved across all groups following aerobic interventions.

Keywords: NEPA; Nordic walking; breast cancer; compensation; menopause; sedentary time; sleep; walking; workout.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Predicted values of SED. Note: each panel displays violin plots representing the distribution of raw data for each group at each time point. Model-predicted means, derived from mixed-effects models and adjusted for relevant covariates, are shown with vertical error bars indicating 95% confidence intervals. Group-colored lines connect pre- and post-predicted means to highlight within-group changes over time. Meno, blue; BCS_Meno, green; BCS_Ind_Meno, orange.
Figure 2
Figure 2
Predicted values of NEPA. Note: each panel displays violin plots representing the distribution of raw data for each group at each time point. Model-predicted means, derived from mixed-effects models and adjusted for relevant covariates, are shown with vertical error bars indicating 95% confidence intervals. Group-colored lines connect pre- and post-predicted means to highlight within-group changes over time. Meno, blue; BCS_Meno, green; BCS_Ind_Meno, orange.
Figure 3
Figure 3
Predicted values of sleep. Note: each panel displays violin plots representing the distribution of raw data for each group at each time point. Model-predicted means, derived from mixed-effects models and adjusted for relevant covariates, are shown with vertical error bars indicating 95% confidence intervals. Group-colored lines connect pre- and post-predicted means to highlight within-group changes over time. Meno, blue; BCS_Meno, green; BCS_Ind_Meno, orange.

References

    1. Lumachi F. Current medical treatment of estrogen receptor-positive breast cancer. World J. Biol. Chem. 2015;6:231. doi: 10.4331/wjbc.v6.i3.231. - DOI - PMC - PubMed
    1. Charehbili A., Fontein D.B.Y., Kroep J.R., Liefers G.J., Mieog J.S.D., Nortier J.W.R., Van de Velde C.J. Neoadjuvant hormonal therapy for endocrine sensitive breast cancer: A systematic review. Cancer Treat. Rev. 2014;40:86–92. doi: 10.1016/j.ctrv.2013.06.001. - DOI - PubMed
    1. Fabian C.J. The what, why and how of aromatase inhibitors: Hormonal agents for treatment and prevention of breast cancer: Hormonal agents for treatment and prevention of breast cancer. Int. J. Clin. Pract. 2007;61:2051–2063. doi: 10.1111/j.1742-1241.2007.01587.x. - DOI - PMC - PubMed
    1. An K.C. Selective Estrogen Receptor Modulators. Asian Spine J. 2016;10:787. doi: 10.4184/asj.2016.10.4.787. - DOI - PMC - PubMed
    1. Chew H.K. Adjuvant therapy for breast cancer: Who should get what? West. J. Med. 2001;174:284–287. doi: 10.1136/ewjm.174.4.284. - DOI - PMC - PubMed

LinkOut - more resources